ArticleBMC cancer2022

RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers.

Zhouting Tuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.